| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 169,647 | 173,549 | 164,990 | 207,378 | | Cost of Revenue | 105,457 | 108,974 | 102,677 | 120,921 | | | Gross Profit | 64,190 | 64,575 | 62,313 | 86,457 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 58,011 | 78,129 | 72,302 | 89,822 | | Non Recurring | 12,279 | (4,386) | 5,935 | 73,392 | | Others | 2,741 | 2,838 | 3,790 | 3,420 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (8,841) | (12,006) | (19,714) | (80,177) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 99 | 55 | 619 | 1,813 | | Earnings Before Interest And Taxes | (9,211) | (11,951) | (19,095) | (78,364) | | Interest Expense | (372) | 181 | 191 |
-
| | Income Before Tax | (8,839) | (12,132) | (19,286) | (78,364) | | Income Tax Expense | (1,215) | 2,974 | (4,059) | (95) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,624) | (15,106) | (15,227) | (78,269) | | | Non-recurring Events | | Discontinued Operations | 770 | (2,665) | 9,668 | (2,060) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (6,854) | (17,771) | (5,559) | (80,329) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($6,854) | ($17,771) | ($5,559) | ($80,329) |
|
0.51% Nasdaq 
Income Statement
